Inventor
LINDERS JOANNES THEODORUS MARIA
BE24 patents
⚠️ This page may combine multiple inventors who share the name “LINDERS JOANNES THEODORUS MARIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
13 patentsUS7816360B2Oct 19, 2010
MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
JANSSEN PHARMACEUTICA NV9 citations83
US7504400B2Mar 17, 2009
MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles
JANSSEN PHARMACEUTICA NV8 citations83
US7968601B2Jun 28, 2011
Adamantyl acetamides as 11-β hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV15 citations80
US7687644B2Mar 30, 2010
Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV12 citations79
US8344181B2Jan 1, 2013
N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV6 citations71
US9630921B2Apr 25, 2017
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US9422284B2Aug 23, 2016
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US9150512B2Oct 6, 2015
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US9040725B2May 26, 2015
Benzocycloheptane and benzoxepine derivatives
JANSSEN PHARMACEUTICA NV0 citations50
US9776965B2Oct 3, 2017
Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV0 citations47
US9302987B2Apr 5, 2016
Pyrrolidinyl derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV0 citations47
US9227935B2Jan 5, 2016
Piperidine/piperazine derivatives
JANSSEN PHARMACEUTICA NV0 citations47
US9724418B2Aug 8, 2017
Drug combinations comprising a DGAT inhibitor and a PPAR-agonist
JANSSEN PHARMACEUTICA NV0 citations46